Condition	Additional Trial Information
Anticoagulant Reversal	Efficacy and Safety Study of BERIPLEX® P/N Compared With Plasma in Patients on Anticoagulant Therapy Who Require Emergency Surgery or Invasive Intervention > Learn More
Acute Major Bleeding: Blood Coagulation Disorders	Efficacy and Safety Study of BERIPLEX® P/N Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy > Learn More
Congenital Fibrinogen Deficiency	Fibrinogen Concentrate (Human) − Efficacy and Safety Study > Learn More
Emphysema Caused by API Deficiency	Study of Zemaira i.v. Administration in Subjects Who Completed a 2-Year Controlled Study With This Treatment and Have Emphysema Due to alpha1 -Proteinase Inhibitor Deficiency. > Learn More
Emphysema Caused by API Deficiency	Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency > Learn More
Factor XIII Deficiency	A Study of the Use of Factor XIII Concentrate in Patients with Inherited FXIII Deficiency > Learn More
Factor XIII Deficiency	A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency > Learn More
Healthy	Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers > Learn More
Hemophilia A	Study of a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII) , Biostate®, in Subjects with Hemophilia A > Learn More
Hereditary Angioedema	C1 Esterase Inhibitor in HAE (Extension Study) > Learn More
Primary Immune Deficiency	Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency > Learn More
Von Willebrand Disease	Study of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII), Biostate®, in Subjects With Von Willebrand Disease > Learn More

> Learn how to participate in clinical trials
> Learn more about our products

Choose country

Current Studies